结肠炎诱导的腹腔替换增加了腹腔心律失常的风险
Carlos H Pereira1, Hiroki Kittaka1, Edward J Ouille V1
1Department of Internal Medicine/Cardiology, Rush University Medical Center, 1750 W. Harrison St., Chicago, IL 60612, USA.
Journal of molecular and cellular cardiology
|May 23, 2025
概括
炎症性肠道疾病通过改变心脏通过氨酸-血管新生素系统处理来增加心律失常的风险. 抑制这个系统 (ACE或AT1R阻断剂) 可以防止这些心脏变化.
科学领域:
- 心脏病学 心脏病学
- 胃肠病学 胃肠病学
- 分子生物学分子生物学
背景情况:
- 炎症性肠病 (IBD) 与心脏导电缺陷和心室节律失常的风险增加有关.
- 肠道功能失调,全身炎症和氨酸-血管素系统 (RAS) 放松调节与IBD有关,可能导致心脏并发症.
研究的目的:
- 研究大肠炎诱导电生理学重塑并增加心室失常风险的机制.
- 探索氨酸 - 血管酶系统在结肠炎相关的心脏电动不稳定性的作用.
主要方法:
- 用牛硫酸诱导的大肠炎的小鼠模型来评估活跃炎症期间的心脏电生理学.
- 进行了心电图,兰登多夫透气心电生理学 (现场潜力记录) 和隔离的腹腔肌细胞研究 (过时分析).
- 评估了SERCA激活剂 (伊斯塔洛キシ姆) 和RAS抑制剂 (ACE抑制剂,AT1R抑制剂) 的作用.
主要成果:
- 大肠炎诱导了延长的QT持续时间,增加了场潜在分散,以及更高的倾向心室替代.
- 隔离的肌细胞显示的过渡替代物增加和持续时间延长,与缩的索兰酸化有关.
- 抑制氨酸-血管氨系统 (ACE或AT1R阻塞) 阻止了替代剂诱导性增加.
结论:
- 活跃性结肠炎促进了心室处理的可逆改造,增加了心律失常的风险.
- 宁-血管激素系统的激活在这些结肠炎引起的心脏电生理学变化中起着关键作用.
- 针对RAS可能为患有活跃炎症性肠病的患者管理心脏风险提供治疗效益.
更多相关视频
相关概念视频
Disturbances in Heart Rhythm
919
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
919
Mechanism of Cardiac Arrhythmias
901
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
901
Inflammatory Bowel Disease I: Ulcerative Colitis
159
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
159
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
935
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
935
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
719
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
719


